[ BILL & MELINDA GATES FOUNDATION - Universal Influenza Vaccine Development Grand Challenge | Research Funding ]

Thumbnail

Event details

Date and time 22.06.2018  
Category Call for proposal
Aim: the Bill & Melinda Gates Foundation and the Page Family are launching the "Universal Influenza Vaccine Development Grand Challenge" during the centenary year of the 1918 flu pandemic. The goal of this Grand Challenge is to identify novel, transformative concepts that will lead to development of universal influenza vaccines offering protection from morbidity and mortality caused by all subtypes of circulating and emerging (drifted and shifted) Influenza A subtype viruses and Influenza B lineage viruses for at least three to five years. It is envisaged that such a universal influenza vaccine would address the threat from both seasonal and pandemic influenza, thus alleviating the need for annual seasonal influenza vaccination campaigns, averting significant global morbidity and mortality, and better preparing the world for the next influenza pandemic.
 
Funding: Pilot awards up to USD $2 million
 
Duration: Expected duration of 2 years. The goal is to develop universal influenza vaccines that are ready to start clinical trials by 2021.
 
Eligibility: Grand Challenges are open to both foreign and domestic organizations, including non-profit organizations, for-profit companies, international organizations, government agencies and academic institutions.
 
How to Apply: Applicants should first submit a letter of interest (LOI) detailing their research idea. The LOI should highlight the goals, study design, investigator capabilities, and budget for the project. The most promising applicants will then be invited to submit a full proposal.
 
Application Deadline: LOI due 22 June 2018, 11:30 am PST (20:30 CEST)
 
Further information
  • More details on the call can be found here.
  • Summaries of successful Grand Challenge grants can be found here.
  • For any other questions, contact the Research Office.

Practical information

  • General public
  • Free

Contact

Tags

research funding

Event broadcasted in

Share